“Opponents of legalizing cannabis for medicinal purposes are fond of arguing that the plant must be subjected to the same standards of clinical study and FDA review as conventional medicines. According to a just-published analysis of some 200 newly FDA-approved medications, few conventional drugs are tested in multiple, large-scale clinical assessing safety and efficacy trials prior to market approval. By comparison, there exists over 20,000 published studies or reviews in the scientific literature referencing the cannabis plant and its cannabinoids, nearly half of which were published within the last five years.”
http://www.hightimes.com/read/cannabis-has-been-studied-more-many-fda-approved-pharmaceuticals
Related posts:
Law Prof Specializing In Poverty Makes $205K Teaching One Class
18 Signs That Global Financial Markets Are Entering A Horrifying Death Spiral
Glenn Greenwald: Obamacare architect leaves White House for pharmaceutical industry job
New Spying Apparatus Installed Throughout Downtown Seattle
WikiLeaks’ ‘CableGate’ Server Up for Auction on eBay
Biden in 2006 schools Obama in 2013 over NSA spying program
John Templeton, R.I.P.
Non-Muslims Carried Out More than 90% of All Terrorist Attacks on U.S. Soil
Why the BBC Fails to Care
Behind 'Deep Web': Alex Winter's excellent Bitcoin adventure
IRS Official in Charge During Tea Party Targeting Now Runs IRS Obamacare Office
Secret terrorism court orders declassification of its own rulings
Pot Grower Demands Speedy Trial, Is Imprisoned For 6 Years Without Trial
Cyprus: 16 months of capital controls, banks still pitifully capitalized
Bitcoin in Israel: Interview with Meni Rosenfeld and Ron Gross, Part I